Sarruf v. Lilly Long Term Disability Plan

District Court, W.D. Washington·Decided July 3, 2025·No. 2:24-cv-00461·Unknown

Opinion

THE HONORABLE JOHN C. COUGHENOUR UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON DAVID SARRUF, CASE NO. C24-0461-JCC Plaintiff, ORDER v. LILLY LONG TERM DISABILITY PLAN and LILLY LIFE INSURANCE PLAN, Defendants.

This matter comes before the Court on Plaintiff David Sarruf’s and Defendants Lilly Long Term Disability Plan’s and Lilly Life Insurance Plan’s cross-motions for summary judgment. (Dkt. Nos. 45, 46.) Having thoroughly considered the briefing and record, and finding oral argument unnecessary,1 the Court GRANTS in part and DENIES in part each motion for the reasons explained below. The cross-motions follow Mr. Sarruf’s complaint (Dkt. No. 1) seeking a determination that he is entitled to long-term disability (“LTD”) and life insurance waiver of premium (“LWOP”) benefits under the terms of the Lilly Long Term Disability Plan (the “LTD Plan”) and

1 Oral argument is unnecessary because each party has had a full opportunity to brief issues presented in their motions. See Partridge v. Reich, 141 F.3d 920, 926 (9th Cir. 1998). Lilly Life Insurance Plan, pursuant to Section 502(a)(1)(B) of the Employee Retirement Income Security Act (“ERISA”). (See generally Dkt. Nos. 45, 46.) According to the administrative record before the Court, (Dkt. Nos. 43, 43-1), Plaintiff ceased working for Eli Lilly and Company after developing post-COVID viral syndrome, i.e., long COVID, beginning in March 2020. (Dkt. No. 43-1 at 344, 1908.) Shortly thereafter, Plaintiff applied for LTD benefits. (Dkt. No. 43 at 578.) The LTD Plan administrator denied Plaintiff’s benefit claim, citing (a) insufficient medical support and (b) Plaintiff’s failure to follow a prescribed course of treatment, as required by the LTD Plan. (Id. at 193–225, 276–77.) Plaintiff then retained counsel and attempted to appeal this decision. (See, e.g., id. at 675.) As a threshold matter, the Court notes significant confusion amongst all parties as to the cut-off date for the internal appeal of the LTD Plan administrator’s benefits denial. For example, the administrator’s denial letter stated, in part, that “[y]ou have 240 days after the declared end of the current national emergency to appeal the determination,” referring to the COVID-19 federal public health emergency. (Id. at 277.) But a few months later, the LTD Plan incorporated COVID-19 tolling relief, pausing the appeal deadline “until the earlier of (a) one year from the date the individual was first eligible for relief, or (b) 60 days after the announced end of the national emergency.” (Id. at 142, 196.) Based on this, according to Defendants’ briefing in this matter, Plaintiff’s appeal deadline was April 26, 2022. (See, e.g., Dkt. Nos. 46 at 21, 22; 53 at 14.) Just prior to this date, Plaintiff’s counsel sent a letter to the LTD Plan administrator (a) notifying them of Plaintiff’s intent2 to appeal the denial of LTD and LWOP benefits, (b) requesting confirmation of the appeal deadline, and (c) seeking copies of Plaintiff’s claim files (so as to fully support the anticipated appeal). (Dkt. No. 43 at 675–79.) Following further clarification requests from Plaintiff’s counsel, Defendants’ representative eventually responded

Free access — add to your briefcase to read the full text and ask questions with AI

Sarruf v. Lilly Long Term Disability Plan, (W.D. Wash. 2025).

Sarruf v. Lilly Long Term Disability Plan (Sarruf v. Lilly Long Term Disability Plan) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related